WHISTLEBLOWER REPRISAL INVESTIGATION

HONEYWELL INTERNATIONAL INC. MINNEAPOLIS, MINNESOTA (Report No. DODIG-2025-087)

WHISTLEBLOWER REPRISAL INVESTIGATION

Management Advisory:

The DoD’s FY 2024 Compliance with the Federal Information Security Modernization Act of 2014 (Report No. DODIG-2025-086)

Management Advisory:

Evaluation of the U.S. Navy’s Efforts

to Prevent and Respond to Incidents of Deaths by Suicide, Suicide Attempts, and Suicidal Ideation (Report No. DODIG-2025-085)

Evaluation of the U.S. Navy’s Efforts

Evaluation of DoD

Roles and Processes Leading up to the July 2023 Basing Decision for the U.S. Space Command (Report No. DODIG-2025-084)

Evaluation of DoD

Audit of Department of Defense Lowest Price Technically Acceptable Contract Awards (Report No. DODIG-2025-083)



Audit of Department of Defense Lowest Price Technically Acceptable Contract Awards (Report No. DODIG-2025-083)

Management Advisory:

Air Force Actions to Identify and Respond to Harassment of Service Members (Report No. DODIG-2025-082)

Management Advisory:

Audit of Storage of U.S. Army Prepositioned Stocks in Belgium and the Netherlands (Report No. DODIG-2025-081)



Audit of Storage of U.S. Army Prepositioned Stocks in Belgium and the Netherlands (Report No. DODIG-2025-081)

Click here for the Ukraine Response Homepage

Click here for the Open Careers Homepage

Click here for the Open Recommendations Homepage

Click for Hotline Homepage

Press Release: Evaluation of Incurred Cost Audits Performed by Non Federal Auditors for Compliance with Government Auditing Standards (Report No. DODIG-2025-062)
Jan. 23, 2025
The Department of Defense Office of Inspector General (DoD OIG) announced today that it released the “Evaluation of Incurred Cost Audits Performed by Non-Federal Auditors for Compliance with Government Auditing Standards.” “Government Auditing Standards are crucial because they ensure the integrity, accountability, and transparency of Government operations,” said IG Storch.
Press Release: Audit of the DoD Government Travel Charge Card Program: The Visa IntelliLink Compliance Management System (DODIG-2025-060)
Jan. 23, 2025
The Department of Defense Office of Inspector General (DoD OIG) announced today that it released the “Audit of the DoD Government Travel Charge Card Program: The Visa IntelliLink Compliance Management System.” The DoD OIG found that the DoD’s Government Travel Charge Card (GTCC) program officials did not effectively use policies, procedures, or the Visa IntelliLink Compliance Management data mining system (VICM system) to identify misuse, abuse, or potential fraud. The Defense Travel Management Office’s (DTMO) implementation and management of the VICM system limited the system’s effectiveness in identifying and assisting reviewers in investigating high-risk GTCC transactions where misuse, abuse, and fraud were more likely.
Press Release: Audit of the Army’s Management of Undefinitized Contract Actions Awarded to Provide Ukraine Assistance (Report No. DODIG-2025-059)
Jan. 21, 2025
The Department of Defense Office of Inspector General (DoD OIG) announced today that it released the “Audit of the Army’s Management of Undefinitized Contract Actions Awarded to Provide Ukraine Assistance.”
Read More
WHISTLEBLOWER REPRISAL INVESTIGATION HONEYWELL INTERNATIONAL INC. MINNEAPOLIS, MINNESOTA (Report No. DODIG-2025-087)
April 23, 2025
We conducted this investigation in response to a reprisal complaint alleging that Honeywell International Inc. (Honeywell), Minneapolis, Minnesota, directed its subcontractor to remove the Complainant from the Honeywell defense contract in reprisal for making protected disclosures to Honeywell officials concerning political and racist comments, neglected security duties, falsified time, and illegal drug activity.
Management Advisory: The DoD’s FY 2024 Compliance with the Federal Information Security Modernization Act of 2014 (Report No. DODIG-2025-086)
April 16, 2025
This management advisory provides recommendations related to the DoD Office of Inspector General’s review of the DoD’s compliance with the Federal Information Security Modernization Act of 2014 (FISMA), which we announced on December 11, 2023 (Project No. D2024 D000CP 0043.000). However, the results in this management advisory do not fully represent all the requirements for each metric or the DoD’s overall FISMA rating.
Evaluation of the U.S. Navy’s Efforts to Prevent and Respond to Incidents of Deaths by Suicide, Suicide Attempts, and Suicidal Ideation (Report No. DODIG-2025-085)
April 15, 2025
We assessed and summarized the Navy’s efforts to prevent and respond to suicide related incidents on six specific topics, as required by section 599A of the FY 2023 National Defense Authorization Act (NDAA).
Read More
U.S. Attorney Announces $202 Million Settlement With Gilead Sciences For Using Speaker Programs To Pay Kickbacks To Doctors To Induce Them To Prescribe Gilead’s Drugs
April 29, 2025
Gilead Admits to Paying Hundreds of Thousands of Dollars to High Prescribers of Gilead’s HIV Drugs to Serve as Speakers at Programs and to Holding Programs at Luxury Restaurants Jay Clayton, the United States Attorney for the Southern District of New York; Naomi Gruchacz, the Special Agent in Charge of the New York Regional Office of the U.S. Department of Health and Human Services, Office of Inspector General (“HHS-OIG”); Christopher M. Silvestro, the Acting Special Agent in Charge of the Northeast Field Office of the Defense Criminal Investigative Service (“DCIS”), the law enforcement arm of the Department of Defense’s Office of Inspector General (“DOD-OIG”); and Christopher G. Raia, the Assistant Director in Charge of the New York Field Office of the Federal Bureau of Investigation (“FBI”), announced today that the U.S. has settled a civil fraud lawsuit against GILEAD SCIENCES, INC (“GILEAD”), a large pharmaceutical manufacturer, that, among other things, develops, manufactures, and sells drugs for the treatment of infectious diseases, including HIV/AIDS. The settlement resolves claims that GILEAD offered and paid kickbacks in the form of honoraria payments, meals, and travel expenses to healthcare practitioners who spoke at or attended Gilead speaker events to induce them to prescribe Stribild®, Genvoya®, Complera®, Odefsey®, Descovy®, and Biktarvy® (the “Gilead HIV Drugs”) in violation of the Anti-Kickback Statute (“AKS”) and thereby caused false claims for the Gilead HIV Drugs to be submitted to and paid by federal healthcare programs in violation of the False Claims Act.
Lawton-Area Trio Sentenced to Serve More Than 12 Years Collectively in Federal Prison for Health Care Fraud
April 22, 2025
JIMMIE MATHEWS, 41, NATHAN MATHEWS, 42, and AMBER DELGER, 55, all of the Lawton area, have been sentenced for their roles in a conspiracy to commit health care fraud, announced U.S. Attorney Robert J. Troester.
Subcontractor Pleads Guilty to Conspiracy to Bribe General Services Administration Official
April 21, 2025
A Mt. Airy, Maryland, man pled guilty to conspiring to bribe a U.S. General Services Administration (GSA) official, wire fraud in connection with an Economic Injury Disaster Loan, and possession of a machine gun with an obliterated serial number.

Read More